Cell Impact AB (Nasdaq First North GM: CI B) has received an order worth MSEK 1.3 for serial production of bipolar flow plates from Beijing-based Nowogen Technology in China. The order is a continuation of the prototype order that Nowogen placed in September last year.
This is the first order for serial production of flow plates based on Nowogen's flow plate design.
For more information, please contact:
Mr. Pär Teike, CEO, +46 73-024 06 84 or paer.teike@cellimpact.com.
About Cell Impact
Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming™, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional forming methods.
The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Advisor (CA). Contact info: +46 8-528 00 399 or info@fnca.se.
This information is information that Cell Impact AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
Subscribe to automatically receive our press releases in your mailbox.
Prenumerera för att automatiskt få våra pressmeddelanden till din epost.
